Cost Implications of Anticoagulation Strategies After Percutaneous Coronary Intervention Among Patients With Atrial Fibrillation (A PIONEER-AF PCI Analysis)

Authors:

Abstract
No abstract available
Funding Information
  • Janssen Pharmaceutica
  • Janssen Scientific Affairs (472840)
  • Bayer

This publication has 11 references indexed in Scilit: